Improvement of the quality of care through standardized documentation

Improvement of the quality of care through standardized documentation - VERSUS

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00015762

Enrollment

999999

Registered

2018-10-22

Start date

2018-06-04

Completion date

Unknown

Last updated

2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C61 C67 C64 C62 C66 C60 C68 C65

Interventions

Group 1: Documentation of clinical data on the history, diagnosis, findings, course of disease and therapies of patients with urological tumors

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Men and Women with verified urological cancer

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Overall survival (OS) and Cancer-specific survival (CS) stratified for guideline adherence	—

Secondary

Measure	Time frame
Number of documented patients per quarter / year and comparison with data on incidence and prevalence (Robert Koch Institute, cancer registry), recording of drug interactions / side effects for oncological drugs per quarter / year and comparison with the respective registration studies, recording of nicotine abuse and occupational noxae per new diagnosis of urothelial carcinoma, recording the number of patients reported to the second opinion centers and the number of subsequent therapy modifications. comparison of follow-up care in the practices of the association for quality assurance in Uro-Oncology in Germany e.V. with guideline recommendations. Frequency of use of Active Surveillance and Fertility Protection.	—

Measure

Time frame

Number of documented patients per quarter / year and comparison with data on incidence and prevalence (Robert Koch Institute, cancer registry), recording of drug interactions / side effects for oncological drugs per quarter / year and comparison with the respective registration studies, recording of nicotine abuse and occupational noxae per new diagnosis of urothelial carcinoma, recording the number of patients reported to the second opinion centers and the number of subsequent therapy modifications. comparison of follow-up care in the practices of the association for quality assurance in Uro-Oncology in Germany e.V. with guideline recommendations. Frequency of use of Active Surveillance and Fertility Protection.

—

Countries

Germany

Contacts

Public ContactElke Hempel

d-uo Deutsche Uro-OnkologenInteressenverband zur Qualitätssicherung in der Uro-Onkologie in Deutschland e.V.Geschäftsstelle Berlin

info@smgf.de+493028445005

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026